China Resources Double-crane Pharmaceutical Co., Ltd. Class ASSE: 600062

Announcement on Wholly-Owned Subsidiary China Resources Saike Pharmaceutical Co., Ltd. Obtaining the Drug Registration Certificate for Bisoprolol and Amlodipine Tablets

· Issued by China Resources Double-crane Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Wholly-Owned Subsidiary China Resources Saike Pharmaceutical Co., Ltd. Obtaining the Drug Registration Certificate for Bisoprolol and Amlodipine Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment